You are here

News

subscribe

The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.

10 April 2015

First successful use of synthetic antibodies against HIV in humans

The first human trial with newly designed synthetic antibodies showed a 300-fold reduction of viral load in trial participants, as reported in the journal, Nature. The antibodies, known as 3BNC117, are designed to block the key viral protein receptor, HIV’s entry point into the blood cells. The designed antibody attaches itself to the proteins on the outside of HIV itself, making it difficult for the virus to connect to blood cells.

0